Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

Charles Rudolph Walgreen

Walgreens Boots Alliance, Inc.

Fundação Altino Ventura focuses on expanding assistance and establishing partnerships for the professional inclusion of people with disabilities and their caregivers.

Fundação Altino Ventura

Abarca Health provides pharmacy benefit management solutions focused on improving healthcare access and cost management. The company is self-described as a partner for growth and innovation in the pharmacy care sector.

Abarca Health

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Metric
Company Name	Walgreens Boots Alliance, Inc.	Fundação Altino Ventura	Abarca Health	AmerisourceBergen Corporation
Symbol	WBA			ABC
MSH ID	COM:WALGREENSBOOTSALLIANCE	BR:ORG:FUNDACAOALTINOVENTURA	COM:ABARCAHEALTH	COM:AMERISOURCEBERGEN
Market	STOCKS	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare	Public & Social Sector	Healthcare & Health Services	Healthcare
Industry	Medical - Pharmaceuticals	Non-Profit Organization	Pharmacy Benefit Management	Medical - Distribution
Country	US	BR	US	US
Stage
Employee Count	206K			46K
Website	walgreensbootsalliance.com	fundacaoaltinoventura.org.br	abarcahealth.com	amerisourcebergen.com
LinkedIn			abarcahealth
Founders

Metric
Market Cap	9.72B	36.15B
Enterprise Value
Monthly Web Traffic	109.45K
Web Traffic Growth	1.08
Valuation
Raised Capital

Metric
Revenue	147.66B	293.96B
Revenue (LTM)
Revenue (NTM)
Gross Profit	26.52B	9.91B
EBITDA	2.25B	3.24B
Operating Income	-14.08B	2.18B
Net Income	-8.64B	1.51B
EPS	-10.01	7.60
Diluted EPS	-10.01	7.53
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.19	0.03
Operating Profit Margin	0.00	0.01
EBITDA Margin	-0.01	0.01
Net Profit Margin	0.00	0.01
Return on Equity	0.01	2.48
Return on Assets	0.00	0.03
Return on Capital Employed	0.00	0.20

COM:WALGREENSBOOTSALLIANCE

Walgreens Boots Alliance

Last Close

8.30

22/11 21:00

Market Cap

9.72B

Beta: -

Volume Today

20.11M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	80.32	21.56
P/B Ratio	0.69	39.50
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.13	0.17
EV Multiple	2.35	11.87

Metric
Days Sales Outstanding	15.31	29.83
Days Payables Outstanding	42.95	64.99
Days Inventory Outstanding	29.87	25.96
Operating Cycle	45.18	55.56
Cash Conversion Cycle	2.64	-7.62
Asset Turnover	2.21	4.33

Metric
Operating Cash Flow	1.02B	3.48B
Free Cash Flow	-363M	3.00B
Cash Flow to Debt	0.11	0.91
Operating Cash Flow/Sales	0.01	0.02
Free Cash Flow Yield	-0.03	0.08

Metric
Cash & Equivalents	1.32B	3.13B
Accounts Receivable	-464M	-2.78B
Inventory	8.32B	20.17B
Goodwill	15.51B
Debt to Capitalization	0.73	0.84
Debt to Assets	0.34	0.08
Current Ratio	0.66	0.88
Quick Ratio	0.37	0.55

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.00	0.00
R&D to Revenue
SG&A to Revenue